CRIS Current Research Information System

PALAZZINI, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.624
AS - Asia 5.261
EU - Europa 3.836
SA - Sud America 370
AF - Africa 344
Continente sconosciuto - Info sul continente non disponibili 306
OC - Oceania 9
Totale 16.750
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.457
VN - Vietnam 1.584
SG - Singapore 1.348
CN - Cina 1.200
IT - Italia 1.061
GB - Regno Unito 786
DE - Germania 416
HK - Hong Kong 389
SE - Svezia 285
FR - Francia 265
BR - Brasile 248
UA - Ucraina 208
IN - India 195
IE - Irlanda 183
RU - Federazione Russa 165
NL - Olanda 128
CI - Costa d'Avorio 114
CA - Canada 101
FI - Finlandia 88
KR - Corea 87
ZA - Sudafrica 85
JP - Giappone 75
TG - Togo 72
BD - Bangladesh 68
EE - Estonia 60
JO - Giordania 51
AR - Argentina 43
PH - Filippine 42
TH - Thailandia 35
ID - Indonesia 34
BG - Bulgaria 32
AT - Austria 27
CO - Colombia 27
TR - Turchia 27
BE - Belgio 24
SC - Seychelles 23
EC - Ecuador 22
PL - Polonia 22
MX - Messico 21
PK - Pakistan 21
CH - Svizzera 20
IR - Iran 18
TW - Taiwan 18
IQ - Iraq 17
ES - Italia 13
NG - Nigeria 12
CR - Costa Rica 11
GR - Grecia 10
JM - Giamaica 10
UZ - Uzbekistan 10
EG - Egitto 9
MY - Malesia 9
VE - Venezuela 9
AU - Australia 7
PY - Paraguay 7
SA - Arabia Saudita 7
AL - Albania 6
CL - Cile 6
LT - Lituania 6
AE - Emirati Arabi Uniti 5
LB - Libano 5
MA - Marocco 5
PE - Perù 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HN - Honduras 4
KE - Kenya 4
AZ - Azerbaigian 3
HR - Croazia 3
MK - Macedonia 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
RO - Romania 3
SV - El Salvador 3
TN - Tunisia 3
UY - Uruguay 3
GH - Ghana 2
GT - Guatemala 2
HU - Ungheria 2
MD - Moldavia 2
MT - Malta 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
BB - Barbados 1
BY - Bielorussia 1
CD - Congo 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
IL - Israele 1
KG - Kirghizistan 1
Totale 16.429
Salva come PNG Salva come JPEG
Città #
Singapore 892
Southend 677
Ashburn 652
Chandler 515
Fairfield 501
San Jose 432
Hong Kong 370
Ho Chi Minh City 323
Santa Clara 302
Hanoi 296
Wilmington 248
Woodbridge 240
Beijing 202
Dong Ket 197
Princeton 194
Houston 193
Council Bluffs 188
Seattle 185
Dublin 182
Cambridge 172
Ann Arbor 156
Bologna 156
Hefei 156
Boardman 115
Abidjan 114
Los Angeles 105
Lauterbourg 97
Milan 96
Jacksonville 94
New York 87
Padova 78
Nanjing 75
Westminster 75
Lomé 72
Seoul 69
Helsinki 67
Tokyo 67
Turin 64
São Paulo 55
Buffalo 52
Amman 51
Berlin 51
Haiphong 45
Da Nang 44
Dallas 43
Chicago 41
Jinan 40
San Diego 40
Shenyang 40
Rome 35
Guangzhou 34
Medford 30
Sofia 30
Saint Petersburg 29
Hebei 27
Redondo Beach 27
Jiaxing 26
Changsha 24
Des Moines 24
Phoenix 24
Brussels 23
Nanchang 23
Montreal 22
Munich 22
Toronto 22
Shanghai 21
Hangzhou 19
London 19
Bengaluru 18
Mülheim 18
Florence 17
Dearborn 16
Naples 16
Vienna 16
Yubileyny 16
Zhengzhou 16
Can Tho 15
Falls Church 15
Frankfurt am Main 15
Nuremberg 15
Tianjin 15
Warsaw 15
Amsterdam 14
Johannesburg 14
Olalla 14
Orem 14
Paris 14
Chengdu 13
Jakarta 13
San Francisco 13
Biên Hòa 12
Brooklyn 12
Falkenstein 12
Genoa 12
Ninh Bình 12
Redmond 12
Taizhou 12
Abeokuta 11
Bern 11
Denver 11
Totale 10.136
Salva come PNG Salva come JPEG
Nome #
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 287
Is Pulmonary Artery Pulsatility Index (PAPi) a Predictor of Outcome after Pulmonary Endarterectomy? 284
A new CT-score as index of hemodynamic changes in patients with chronic thromboembolic pulmonary hypertension 269
Complicanze del cateterismo cardiaco destro in pazienti con ipertensione polmonare precapillare di grado severo. 268
A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension 266
Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients 264
Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: Real-world insights 256
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 246
Il test acuto di vasoreattività nei pazienti con ipertensione arteriosa polmonare. 245
Effetti emodinamici e funzionali dell'epoprostenolo in associazione agli antagonisti recettoriali dell'endotelina e agli inibitori delle fosfodiesterasi-5 237
Pulmonary Arterial Hypertension associated to connective tissue diseases 235
Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes 227
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension 221
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry 220
Regressione delle alterazioni elettrocardiografiche indicative di ipertrofia ventricolare destra nei pazienti con ipertensione arteriosa polmonare. 217
Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease 210
BMPR2 mutations and survival in pulmonary arterial hypertension: An individual participant data meta-analysis 207
Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration 203
Andamento clinico, emodinamico e dei livelli plasmatici dell’NT-pro BNP in pazienti con ipertensione polmonare precapillare 202
Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. 199
A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines 196
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 196
Effetti del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare idiopatica, associata e cuore polmonare cronico tromboembolico. 192
Significato prognostico dell'aerea del rigurgito tricuspidalico nei pazienti con ipertensione arteriosa polmonare idiopatica trattati secondo le attuali linee guida. 189
Genere femminile e ipertensione arteriosa polmonare: una relazione complessa Female gender and pulmonary arterial hypertension: a complex relationship 187
Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension. 186
Effetti clinici ed emodinamici del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare. 185
Anticoagulant treatment in patients with pulmonary arterial hypertension associated with systemic sclerosis: More shadows than lights 184
European guidelines on pulmonary hypertension: What's new? 182
Confronto tra antagonista recettoriali selettivi e non selettivi dell'endotelina nel trattamento dell'ipertensione arteriosa polmonare. 181
Sildenafil therapy in patients with porto-pulmonary hypertension 179
Current therapeutic approaches to pulmonary arterial hypertension. 179
Pulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors 176
Cardiologia pediatrica. Problematiche cliniche 175
Bronchial artery embolization for the treatment of haemoptysis in pulmonary hypertension 174
Challenges in pulmonary hypertension: Managing the unexpected 173
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 173
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. 170
Pulmonary arterial hypertension. Part II: Medical and surgical treatment 168
Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study 168
Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature. 166
Effetti del sildenafil in soggetti con cuore polmonare cronico tromboembolico 166
Effetti a lungo termine del trattamento con bosentan sulla capacità funzionale e sui parametri emodinamici nei pazienti con ipertensione arteriosa polmonare. 165
[Treatment goals of pulmonary hypertension]. 164
Effetti a lungo termine del trattamento con sildenafil nei pazienti affetti da ipertensione arteriosa polmonare associata a cardiopatie congenite con shunt 164
Rare causes of pulmonary hypertension. Spectrum of radiological findings and review of the literature 162
Pulmonary veno-occlusive disease: the role of CT 161
Reverse remodelling of ECG changes in idiopathic pulmonary arterial hypertension patients responders to chronic treatment with calcium channel blockers 161
Chronic thromboembolic pulmonary disease 160
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension 157
Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools 157
Pulmonary hypertension and systemic sclerosis: the role of highresolution computed tomography. 156
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism 155
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger's Syndrome. 154
Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease 152
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function 150
Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects 150
Pulmonary hypertension due to left heart disease 149
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 147
Exercise training in pulmonary hypertension: improving performance but waiting for outcome 146
Long-term efficacy and safety of sildenafil in precapillary pulmonary hypertension 145
The difficult diagnosis of pulmonary vascular disease in heart failure 145
Epidemiology of patients referred to a specialised pulmonary hypertension center 144
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial 144
Conventional Medical Therapies in the treatment of pulmonary hypertension 143
L. Negro, M. Zavatta, C. Bachetti, E. Beciani, M. Palazzini, S. Romanazzi, E. Leci, M. Grossi, A. Marinelli, S. Gambetti, A. Manes, N. Galiè, A. Branzi 143
Progressi nel trattamento delle malattie della circolazione polmonare 143
Experience with inheritable pulmonary arterial hypertension in a specialised center 142
Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism 142
Long-term therapeutic outcomes in pulmonary arterial hypertension 141
Pulmonary arterial hypertension: Guidelines and unmet clinical needs 141
The burden of comorbidities in pulmonary arterial hypertension 135
Current medical therapies in pulmonary arterial hypertension 134
Evidence for Kaposi's sarcoma-associated herpes virus infection in patients with idiopathic pulmonary arterial hypertension: a case series and review of the literature 133
Pharmacological impact on right ventricular remodelling in pulmonary arterial hypertension 133
Thrombolysis in high-risk patients with acute pulmonary embolism: underuse of a life-saving treatment in the real-world setting 133
Balloon pulmonary angioplasty after pulmonary thromboendarterectomy 133
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial 132
Left Main Coronary Artery Extrinsic Compression in Patients With Pulmonary Arterial Hypertension: Technical Insights and Long-Term Clinical Outcomes After Stenting 131
Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. 129
Long-term outcomes after pulmonary endarterectomy 129
Pulmonary vascular disease due to left heart disease: How to achieve a more accurate approach beyond the haemodynamic phenotype: Reply 125
Pulmonary hypertension 123
Pulmonary artery intimal sarcoma. Problems in the differential diagnosis. I sarcomi intimali dell'arteria polmonare. Problemi di diagnosi differenziale 123
GPs meet rare lung disorders task force factsheet: Pulmonary arterial hypertension 122
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed. 119
Chronic Thromboembolic Pulmonary Hypertension and Chronic ThromboembolicPulmonary Disease (CTEPD): Clinical and Interventional Perspective 116
Left ventricular dimensions in pulmonary arterial hypertension: haemodynamic and exercise correlations 116
Extracorporeal cardiopulmonary support in acute high-risk pulmonary embolism: Still waiting for solid evidence 116
Pulmonary Hypertension: Lessons from Adults 113
Ipertensione polmonare: Necessità di chiarezza tra definizione emodinamica-fisiopatologica, stima ecocardiografica e diagnosi clinica finale. Pulmonary hypertension and the relationships between hemodynamic-pathophysiologic definitions, echocardiographic estimate and final clinical diagnosis: clarification is needed. 112
Treatment goals of pulmonary hypertension. 110
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2 110
Severe Precapillary Pulmonary Hypertension Due to Whipple Disease 102
Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease 102
Left main coronary artery extrinsic compression by enlarged pulmonary artery in patients with pulmonary arterial hypertension 99
Metrics for Success of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension 97
Comparison of different treatment strategies in patients with chronic thromboembolic pulmonary hypertension: a single centre real-world experience 96
Diagnosis of Chronic Thromboembolic Pulmonary Hypertension 82
Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds 74
Totale 16.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.736
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.278 0 0 0 134 123 88 43 100 62 118 303 307
2022/20232.045 202 275 94 266 94 171 62 115 416 96 146 108
2023/2024411 36 78 30 43 29 56 23 12 12 33 34 25
2024/20252.346 79 384 259 162 396 105 166 89 42 151 82 431
2025/20265.137 413 463 398 321 582 279 530 154 1.186 418 231 162
2026/20271.301 233 232 436 400 0 0 0 0 0 0 0 0
Totale 16.750